Onderneming AVEO Pharmaceuticals, Inc. Börse Stuttgart
Aandelen
VPA
US0535881090
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,28 EUR | -0,19% | -10,02% | +20,93% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 13-09-10 | |
Jinchul Jeong
DFI | Director of Finance/CFO | - | - |
Michael Smith
CMP | Compliance Officer | - | - |
Brent Gardner
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jebediah Ledell
COO | Chief Operating Officer | 49 | 01-12-21 |
Stefanie Solomon
CMP | Compliance Officer | - | - |
Anisha Wharton
LAW | General Counsel | - | 01-01-21 |
Danielle Holland
LAW | General Counsel | - | - |
David Crist
SAM | Sales & Marketing | - | 19-10-20 |
Corporate Officer/Principal | - | 01-12-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 58 | 13-09-10 | |
Jaywin Lee
BRD | Director/Board Member | - | 19-01-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 34 763 127 | 34 693 418 ( 99,80 %) | 0 | 99,80 % |
Bedrijfsgegevens
AVEO Pharmaceuticals, Inc.
1 Marina Park Drive 12th floor
02210, Boston
+857 400 0101
http://www.aveooncology.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+4,57% | 96,72 mld. | |
+5,66% | 41,43 mld. | |
-12,80% | 32,7 mld. | |
+80,99% | 29,06 mld. | |
-15,53% | 15,38 mld. | |
-8,70% | 12,97 mld. | |
-12,22% | 11,36 mld. | |
+183,25% | 9,9 mld. | |
+3,60% | 8,93 mld. |
- Beurs
- Aandelen
- Koers AVEO
- Koers VPA
- Onderneming AVEO Pharmaceuticals, Inc.